Meditek issued a public announcement stating that the company intends to bring in strategic investors via its holding subsidiary, Zhejiang Meditek Optical Semiconductor Co., Ltd. The selected strategic investor, Zhejiang Fuzhe Shaoxin Integrated Circuit Industry Fund Partnership (Limited Partnership), is set to infuse RMB 200 million in cash into the optical semiconductor company. This investment is based on a pre-investment valuation of RMB 2.18 billion. Following the capital injection, Fuzhe Shaoxin will secure an 8.4% equity stake in the optical semiconductor firm. The funds raised will be mainly allocated to support the core business operations of the optical semiconductor company, and will also be used for other purposes as mutually agreed upon by Fuzhe Shaoxin.
